SCHEMBL11297369

SCHEMBL11297369

CC(C)Oc1cccc(N(c2ccc(C(=O)NO)cc2)C2CCNC2=O)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 6/20 0.40
▸ HDAC8 Q9BY41 6/20 0.40
▸ ALDH1A1 P00352 4/20 0.37
▸ NPC1 O15118 3/20 0.37
▸ RAB9A P51151 3/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ HPGD P15428 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ MCL1 Q07820 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ HDAC1 Q13547 3/20 0.37
▸ HDAC3 O15379 1/20 0.36
▸ HDAC2 Q92769 1/20 0.36
▸ MAPK14 Q16539 1/20 0.36
▸ SMO Q99835 1/20 0.36
▸ ROCK2 O75116 1/20 0.35
▸ NFKB1 P19838 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11306357 0.91 ALDH1A1 (0.46) HDAC6HDAC8ALDH1A1NPC1RAB9A
SCHEMBL11297424 0.90 HDAC1 (0.43) HDAC6HDAC8ALDH1A1NPC1RAB9A
SCHEMBL11301404 0.87 HDAC8 (0.47) HDAC6HDAC8ALDH1A1NPC1KDM4E
SCHEMBL11301397 0.86 HDAC1 (0.39) HDAC6HDAC8HDAC1HDAC3HDAC2
SCHEMBL11298752 0.83 HDAC8 (0.42) HDAC6HDAC8HDAC1
SCHEMBL11302647 0.83 HDAC6 (0.43) HDAC6HDAC8NPC1HDAC1KMT2A
SCHEMBL11296174 0.82 HDAC8 (0.44) HDAC6HDAC8NPC1RAB9ASMN1; SMN2
SCHEMBL11297519 0.81 HDAC6 (0.43) HDAC6HDAC8ALDH1A1NPC1RAB9A
SCHEMBL11304336 0.81 HDAC6 (0.42) HDAC6HDAC8HDAC1HDAC3HDAC2
SCHEMBL11299083 0.81 HDAC6 (0.42) HDAC6HDAC8NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback